Literature DB >> 19118566

Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation.

Gwen E Dressing1, Carol A Lange.   

Abstract

Multiple laboratories have investigated progesterone receptor (PR) involvement in breast cancer cell cycle progression. There is now a growing body of evidence demonstrating complex interactions between PR and cell cycle regulatory proteins. Here we review the current literature linking PR to cell cycle control and discuss gaps in the current knowledge. A more complete understanding of the relationships between PR and cell cycle regulatory molecules may reveal additional avenues for prevention and treatment of steroid receptor positive breast cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118566      PMCID: PMC4871707          DOI: 10.1016/j.steroids.2008.12.001

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  40 in total

1.  D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.

Authors:  K E Knudsen; W K Cavenee; K C Arden
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

Review 2.  Steroid hormone receptors and their regulation by phosphorylation.

Authors:  N L Weigel
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

4.  Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.

Authors:  E A Musgrove; L J Hunter; C S Lee; A Swarbrick; R Hui; R L Sutherland
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

5.  Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression.

Authors:  C J Burd; C E Petre; H Moghadam; E M Wilson; K E Knudsen
Journal:  Mol Endocrinol       Date:  2004-11-11

Review 6.  Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?

Authors:  Carol A Lange
Journal:  Mol Endocrinol       Date:  2003-10-16

7.  P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor.

Authors:  C McMahon; T Suthiphongchai; J DiRenzo; M E Ewen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

8.  Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.

Authors:  Amy Jo Galliher-Beckley; Jason Grant Williams; Jennifer Brady Collins; John Anthony Cidlowski
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

9.  Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.

Authors:  I B Rosenwald; R Kaspar; D Rousseau; L Gehrke; P Leboulch; J J Chen; E V Schmidt; N Sonenberg; I M London
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

10.  Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.

Authors:  Jorge S Reis-Filho; Kay Savage; Maryou B K Lambros; Michelle James; Dawn Steele; Robin L Jones; Mitch Dowsett
Journal:  Mod Pathol       Date:  2006-04-28       Impact factor: 7.842

View more
  17 in total

1.  ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.

Authors:  Christy R Hagan; Tarah M Regan; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

Review 2.  Role of phosphorylation in progesterone receptor signaling and specificity.

Authors:  Christy R Hagan; Andrea R Daniel; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Endocrinol       Date:  2011-09-16       Impact factor: 4.102

3.  Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.

Authors:  Gwen E Dressing; Todd P Knutson; Matthew J Schiewer; Andrea R Daniel; Christy R Hagan; Caroline H Diep; Karen E Knudsen; Carol A Lange
Journal:  Mol Endocrinol       Date:  2014-02-25

Review 4.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

5.  Progesterone inhibits the growth of human neuroblastoma: in vitro and in vivo evidence.

Authors:  Fahim Atif; Iqbal Sayeed; Seema Yousuf; Tauheed Ishrat; Fang Hua; Jun Wang; Daniel J Brat; Donald G Stein
Journal:  Mol Med       Date:  2011-06-17       Impact factor: 6.354

Review 6.  Uterine glands: development, function and experimental model systems.

Authors:  Paul S Cooke; Thomas E Spencer; Frank F Bartol; Kanako Hayashi
Journal:  Mol Hum Reprod       Date:  2013-04-25       Impact factor: 4.025

7.  Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control.

Authors:  Yue Yu; Liangliang Liu; Ning Xie; Hui Xue; Ladan Fazli; Ralph Buttyan; Yuzhuo Wang; Martin Gleave; Xuesen Dong
Journal:  J Clin Endocrinol Metab       Date:  2013-05-10       Impact factor: 5.958

8.  Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.

Authors:  Hwa Hwa Chung; Siu Kwan Sze; Alvin Shun Long Tay; Valerie C-L Lin
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

9.  Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.

Authors:  Caroline H Diep; Nathan J Charles; C Blake Gilks; Steve E Kalloger; Peter A Argenta; Carol A Lange
Journal:  Cell Cycle       Date:  2013-04-10       Impact factor: 4.534

10.  Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.

Authors:  Thu H Truong; Amy R Dwyer; Caroline H Diep; Hsiangyu Hu; Kyla M Hagen; Carol A Lange
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.